http://www.jci.org/articles/view/34764
Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model
AKT mTOR
7.10.2008
http://www.jci.org/articles/view/33337
Ablation of PI3K blocks BCR-ABL leukemogenesis in mice, and a dual PI3K/mTOR inhibitor prevents expansion of human BCR-ABL+ leukemia cells
mTOR
24.5.2008